Market Place
Sourcing Support
Clearside Bio Partners with Arctic Vision for Uveitic Macular Edema
07 Nov 2024 //
GLOBENEWSWIRE
Clearside Biomedical to Join Fireside Chat at Stifel Healthcare
06 Nov 2024 //
GLOBENEWSWIRE
Clearside Biomedical Appoints Tony Gibney as Board Chair
04 Nov 2024 //
GLOBENEWSWIRE
Clearside Bio to Report Q3 2024 Financial Results Nov 12, 2024
31 Oct 2024 //
GLOBENEWSWIRE
Clearside Highlights Positive AMD Data At AAO 2024
22 Oct 2024 //
GLOBENEWSWIRE
Clearside`s CLS-AX excels in phase 2b trial, set for phase 3
10 Oct 2024 //
FIERCE PHARMA
Clearside Reports Positive ODYSSEY Phase 2b Results
09 Oct 2024 //
GLOBENEWSWIRE
Clearside Biomedical Completes Final Visit In ODYSSEY Phase 2b Trial
27 Aug 2024 //
GLOBENEWSWIRE
Clearside Biomedical Announces Q2 2024 Results And Corporate Update
12 Aug 2024 //
GLOBENEWSWIRE
Clearside Biomedical To Participate In H.C. Wainwright Conference
08 Aug 2024 //
GLOBENEWSWIRE
Clearside Biomedical To Report Q2 2024 Results On August 12
01 Aug 2024 //
GLOBENEWSWIRE
Clearside`s Partner Reports Positive Phase 3 Results For ARCATUS In China
29 Jul 2024 //
GLOBENEWSWIRE
Clearside Biomedical Opens KOL Webinar Registration For July 24
22 Jul 2024 //
GLOBENEWSWIRE
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board
11 Jul 2024 //
GLOBENEWSWIRE
Clearside Biomedical to Host Virtual Key Opinion Leader Event
27 Jun 2024 //
GLOBENEWSWIRE
Clearside Biomedical`s Suprachoroidal Delivery Featured At Summit
12 Jun 2024 //
GLOBENEWSWIRE
Clearside SCS Consensus Guidelines Published In RETINA Journal
21 May 2024 //
GLOBENEWSWIRE
Clearside Biomedical Q1 2024 Financials And Corporate Update
09 May 2024 //
GLOBENEWSWIRE
Clearside At Citizens JMP Life Sciences Fireside Chat
08 May 2024 //
GLOBENEWSWIRE
Clearside Biomedical Q1 2024 Results & Update on May 9
30 Apr 2024 //
GLOBENEWSWIRE
Clearside Biomedical Appoints Anthony S. Gibney to Board of Directors
16 Apr 2024 //
GLOBENEWSWIRE
Clearside to Participate in Fireside Chat at the Virtual Health Conference
02 Apr 2024 //
GLOBENEWSWIRE
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 Mar 2024 //
GLOBENEWSWIRE
Clearside Bio Announces Fourth Quarter and Full Year 2023 Financial Results
12 Mar 2024 //
GLOBENEWSWIRE
Clearside Bio to Report Fourth Quarter and Full Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 Feb 2024 //
GLOBENEWSWIRE
Clearside Bio Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX
14 Dec 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Clearside to Participate in Fireside Chat at Stifel 2023 Healthcare Conference
08 Nov 2023 //
GLOBENEWSWIRE
Clearside`s Injection Platform Highlighted in Four Ophthalmic Indications
07 Nov 2023 //
GLOBENEWSWIRE
BioCryst and Clearside Biomedical Enter Partnership
03 Nov 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Presentations at the Annual Meeting
02 Nov 2023 //
GLOBENEWSWIRE
Clearside Bio Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX
01 Nov 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Report Third Quarter 2023 Financial Results
31 Oct 2023 //
GLOBENEWSWIRE
Clearside Biomedical Positive OASIS and Extension Study Data Presented
16 Oct 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific
04 Oct 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Participate in a Panel Discussion
03 Oct 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Participate in Panel Discussion
19 Sep 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Participate in Investor Conferences in August 2023
02 Aug 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Report Second Quarter 2023 Financial Results
01 Aug 2023 //
GLOBENEWSWIRE
Clearside Biomedical Highlights Excellent Safety Profile of CLS-AX
31 Jul 2023 //
GLOBENEWSWIRE
Clearside Bio`s Suprachoroidal Injection Platform to be Featured at ASRS
20 Jul 2023 //
GLOBENEWSWIRE
Clearside Biom Announces Enrollment of Participants in Ph 2b Trial of CLS-AX
17 Jul 2023 //
GLOBENEWSWIRE
Clearside Bio CEO George Lasezkay to Present at the SHARE Series Investor Event
11 Jul 2023 //
GLOBENEWSWIRE
Arctic Vision Announces the Acceptance in Australia of NDA for Suprachoroidal Use of Arcatus
10 Jul 2023 //
GLOBENEWSWIRE
Clearside Biomedical Opens Enrollment in ODYSSEY Phase 2b Clinical Trial of CLS-AX
01 Jun 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Participate in a Fireside Chat at the JMP Conference
09 May 2023 //
GLOBENEWSWIRE
Clearside Biomedical to Report 1Q 2023 FYR and Provide Corporate
02 May 2023 //
GLOBENEWSWIRE
Clearside Biomedical Presents Compelling Data at The Association for Research
27 Apr 2023 //
GLOBENEWSWIRE
Clearside Biomedicalâ Suprachoroidal Injection Platform
19 Apr 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Plans for ODYSSEY Ph 2b Clinical Trial of CLS-AX
18 Apr 2023 //
GLOBENEWSWIRE
Clearside to Participate in Fireside Chat at Needham Healthcare Conference
12 Apr 2023 //
GLOBENEWSWIRE
Clearside Enhances Advisory Board with Appointment of Two Retinal Physicians
05 Apr 2023 //
GLOBENEWSWIRE
Clearside Announces Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Clearside to Report Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Trial
21 Feb 2023 //
GLOBENEWSWIRE
Clearside Bio OASIS Data to be Presented at Medical Meetings in February 2023
07 Feb 2023 //
GLOBENEWSWIRE
Clearside Biomedical Announces Leadership Team Update
06 Feb 2023 //
GLOBENEWSWIRE
